Clinical Trial Update: Bosentan for Severe Mitral Valve Dysfunction [Phase 1, Phase 2]

View source ↗

Summary

This document indicates a Phase 1/Phase 2 clinical trial evaluating bosentan for severe mitral valve dysfunction, including secondary pulmonary hypertension and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Mitral Stenosis
• Pulmonary Hypertension
• Rheumatic Fever

Drugs mentioned

• Bosentan (Bosentan)

Snippet

Sponsor: General Hospital of Chalkida | Conditions: SECONDARY PULMONARY HYPERTENSION, MITRAL STENOSIS | Phase 1, Phase 2 | Status: UNKNOWN